Factors Affecting Health-Related Quality of Life After the Arterial Switch Operation.


Journal

World journal for pediatric & congenital heart surgery
ISSN: 2150-136X
Titre abrégé: World J Pediatr Congenit Heart Surg
Pays: United States
ID NLM: 101518415

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 4 5 2021
pubmed: 5 5 2021
medline: 26 11 2021
Statut: ppublish

Résumé

Long-term morbidity and mortality outcomes of the arterial switch operation (ASO) in patients with transposition of the great arteries and Taussig-Bing anomaly are excellent. With an increasing number of patients reaching adolescence and adulthood, more attention is directed toward quality of life. Our study aimed to determine the health-related quality of life (hrQoL) outcomes in patients after the ASO and identify factors influencing their hrQoL. In this cross-sectional study, hrQoL of patients after ASO was assessed with the German version of the Short Form-36 (SF-36) and the potential association of specified clinical factors was analyzed. Patients of at least 14 years of age who underwent ASO in our institution from 1983 were considered eligible. Of the 355 questionnaires sent to eligible patients, 261 (73%) were available for analysis. Compared to the reference population, patients who had undergone ASO had a significantly higher score in all subscales of the SF-36 except for vitality ( Patients' self-assessed and self-reported hrQoL after ASO (using German version of the Short Form 36) is very good. In this population, hrQoL is influenced by reoperation, the need for a pacemaker, and current cardiac medication or anticoagulant use. The development of strategies designed to mitigate or minimize the requirements for, and/or impact of these factors may lead to better hrQoL in this patient population.

Sections du résumé

BACKGROUND BACKGROUND
Long-term morbidity and mortality outcomes of the arterial switch operation (ASO) in patients with transposition of the great arteries and Taussig-Bing anomaly are excellent. With an increasing number of patients reaching adolescence and adulthood, more attention is directed toward quality of life. Our study aimed to determine the health-related quality of life (hrQoL) outcomes in patients after the ASO and identify factors influencing their hrQoL.
METHODS METHODS
In this cross-sectional study, hrQoL of patients after ASO was assessed with the German version of the Short Form-36 (SF-36) and the potential association of specified clinical factors was analyzed. Patients of at least 14 years of age who underwent ASO in our institution from 1983 were considered eligible.
RESULTS RESULTS
Of the 355 questionnaires sent to eligible patients, 261 (73%) were available for analysis. Compared to the reference population, patients who had undergone ASO had a significantly higher score in all subscales of the SF-36 except for vitality (
CONCLUSIONS CONCLUSIONS
Patients' self-assessed and self-reported hrQoL after ASO (using German version of the Short Form 36) is very good. In this population, hrQoL is influenced by reoperation, the need for a pacemaker, and current cardiac medication or anticoagulant use. The development of strategies designed to mitigate or minimize the requirements for, and/or impact of these factors may lead to better hrQoL in this patient population.

Identifiants

pubmed: 33942696
doi: 10.1177/2150135121990651
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-351

Auteurs

Julie Cleuziou (J)

Department of Congenital and Pediatric Heart Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.
Institute for Translational Cardiac Surgery (INSURE), 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.

Anna-Katharina Huber (AK)

Department of Congenital and Pediatric Heart Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.

Martina Strbad (M)

Department of Congenital and Pediatric Heart Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.

Masamichi Ono (M)

Department of Congenital and Pediatric Heart Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.

Alfred Hager (A)

Department of Pediatric Cardiology and Congenital Heart Defects, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.

Jürgen Hörer (J)

Department of Congenital and Pediatric Heart Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.
Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany.

Rüdiger Lange (R)

Institute for Translational Cardiac Surgery (INSURE), 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.
Department of Cardiovascular Surgery, 14924German Heart Center Munich, Technical University of Munich, School of Medicine, Munich, Germany.
German Center for Cardiovascular Research (DZHK)-Partner site Munich Heart Alliance, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH